Printer Friendly

LEAD: 'Nobel effect' to boost Shimadzu sales by 300 mil. yen.

OSAKA, Nov. 19 Kyodo


Shimadzu Corp., whose employee Koichi Tanaka was named co-winner of the 2002 Nobel Chemistry Prize, said Tuesday it expects its group sales will be boosted by 300 million yen on surging demand for a machine that Tanaka had a key role in developing.

The company said sales of mass spectroscopy machines will surge 20%, or 300 million yen, in 2002 over 2001 to 1.5 billion yen.

Shimadzu Managing Director Tadayoshi Fukushima told reporters, ''In addition to drawing a greater number of business inquiries related to our machines from other businesses, (Tanaka) has provided large plus effects to our performances through such effects as boosting the familiarity of our company and improving our corporate image.''

Other effects of the award going in part to Tanaka, who was a researcher in the company's biotechnology division, include greater sales of air purifiers on the basis of individuals buying via mail order, Fukushima said.

Shimadzu announced last month a plan to set up a research institute to commemorate Tanaka's Nobel Prize winning, putting him in charge of the institute.

But the company left unchanged its projections for consolidated sales and net profits for the year to March 31, 2003 at 197 billion yen and 3.5 billion yen, the same as in estimates released in May.

The sales projection represents a year-on-year rise of 2.6%. The 3.5 billion yen net profit compares with a loss of 8.1 billion yen in all of fiscal 2001.

Shimadzu's precision measuring equipment operations, to which Tanaka belongs, will likely account for 109 billion yen of the overall group sales, up 4.2% over the preceding fiscal year, the company said.

Shimadzu said its group net profit in the first six months of fiscal 2002 surged 20-fold to 2.23 billion yen and its pretax balance swung back to the black despite a 1.7% sales shrinkage.

The group pretax profit came to 2.93 billion yen, a turnaround from a loss of 497 million yen, with group sales coming to 94.73 billion yen.

Shimadzu attributed the profit rise to cost cutting and a one-off gain of 1.97 billion yen that stemmed mainly from the sales of a patent. It blamed the overall sales fall to sluggish demand for testing equipment and industrial machinery.

Consolidated per-share net profit jumped to 8.35 yen from 0.42 yen a year earlier.

Shimadzu said it will resume per-share midterm and year-end dividend payments of 2.50 yen and 2.50 yen each. As a result, the full-year dividend will come to 5.0 yen per share.

Although it incurred a group pretax loss of 4.20 billion yen in the preceding fiscal year, Shimadzu said it expects to post a group pretax profit of 6.5 billion yen.
COPYRIGHT 2002 Kyodo News International, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Japan Weekly Monitor
Geographic Code:9JAPA
Date:Nov 25, 2002
Previous Article:LEAD: U.S. trade deficit falls 0.7% in Sept.
Next Article:Diet panel OKs delay in imposing demand deposit refund cap.

Related Articles
Shimadzu falls into pretax loss in FY 2001.
Shimadzu expects Nobel sales boost. (Executive briefing: news, trends & market intelligence for instrument executives).
Shimadzu posts 19.7% rise in interim group pretax profit.
Shimadzu posts record sales in FY 2003.
Shimadzu Launches Compact Desktop Microfocus X-ray CT.
FY 2005 Shimadzu group net profit falls 4.9% to 11.32 bil. yen.
Shimadzu FY06 results: a growing Chinese presence.
Shimadzu and Horiba: China and Europe benefit FY sales.
Analytical instruments drive Shimadzu's growth.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters